Home > Compound List > Product Information
Org 27569_Molecular_structure_CAS_868273-06-7)
Click picture or here to close

Org 27569

Catalog No. O8014 Name Sigma Aldrich
CAS Number 868273-06-7 Website http://www.sigmaaldrich.com
M. F. C24H28ClN3O Telephone 1-800-521-8956
M. W. 409.95162 Fax
Purity ≥98% (HPLC) Email
Storage Chembase ID: 73142

SYNONYMS

IUPAC name
5-chloro-3-ethyl-N-{2-[4-(piperidin-1-yl)phenyl]ethyl}-1H-indole-2-carboxamide
IUPAC Traditional name
5-chloro-3-ethyl-N-{2-[4-(piperidin-1-yl)phenyl]ethyl}-1H-indole-2-carboxamide
Synonyms
5-chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)-ethyl]-amide
5-Chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-ylphenyl)ethyl]amide

DATABASE IDS

MDL Number MFCD11045300
CAS Number 868273-06-7
EC Number 278-169-7

PROPERTIES

Empirical Formula (Hill Notation) C24H28ClN3O
Purity ≥98% (HPLC)
Apperance white powder
Solubility H2O: <2 mg/mL
Solubility DMSO: >5 mg/mL
MSDS Link Download
Personal Protective Equipment Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
Storage Temperature 2-8°C
German water hazard class 3

DETAILS

Description (English)
Biochem/physiol Actions
Org 27569 is an allosteric modulator of CB1 cannabinoid receptor. It significantly increases the binding of CB1 receptor agonist [3H]-CP 55,940 (pKB = 5.67) and causes a significant decrease in specific binding of CB1 receptor inverse agonist SR141716A (Rimonabant; pKB = 5.95); in the reporter gene assay behaves as insurmountable CP 55,940 antagonist; pKB = 7.57 at CB1 receptors in mouse vas deferens
Description (简体中文)
Biochem/physiol Actions
Org 27569 is an allosteric modulator of CB1 cannabinoid receptor. It significantly increases the binding of CB1 receptor agonist [3H]-CP 55,940 (pKB = 5.67) and causes a significant decrease in specific binding of CB1 receptor inverse agonist SR141716A (Rimonabant; pKB = 5.95); in the reporter gene assay behaves as insurmountable CP 55,940 antagonist; pKB = 7.57 at CB1 receptors in mouse vas deferens

REFERENCES